Browse drugs

…N after exclusion of other causes. The infant was discharged on aspirin (3 mg/kg/day) and antihypertensives and remains well on follow-…

… P2Y12 receptor antagonist), mainly with low-dose prasugrel and ticagrelor. Off-label low-dose antiplatelet agents significantly reduced m…

…tients were receiving antiplatelet therapy (APT), predominantly aspirin monotherapy, while no ruptured aneurysm patients received APT. …

…nt CAS between January 2016 and August 2025 and received either ticagrelor or clopidogrel. Primary outcomes at 180 days included ischemic …

…-old man with a history of ischaemic heart disease treated with clopidogrel and aspirin. One month after initiating the treatment he develo…

… post-procedure.Results 150 patients were included: 72 received tirofiban and 78 received dual antiplatelets. AST occurred in 2.8% of the…

…y following flow diverter placement, patients were administered eptifibatide. After the procedure, patients were loaded with a P2Y12 inhibit…

…elor or prasugrel), to the control arm, bare p64-MW under DAPT (ticagrelor or prasugrel+aspirin), for unruptured IA management. The primar…

…venous immunoglobulin and aspirin. The patient was treated with anakinra, an interleukin-1 receptor antagonist, which improved inflammat…

… increases were observed in evidence-based treatment, including aspirin (71.6% among postintervention AMI participants vs 34.4% preinte…

… his significant risk of bleeding, a decision was taken to stop aspirin only to present later with a third episode of renal bleeding. D…

…with PD-L1 blockade. The EORTC-1508GCG phase II trial evaluated atezolizumab (anti-PD-L1), bevacizumab (anti-VEGF), and low-dose aspirin in …